Contact us

New Paper Finds Crystal Polymorphs of Trial Cancer Drug

Paper accepted in Journal of the American Chemical Society
Figure showing the 10 polymorphs of galunisertib

Prof Colin Pulham and Dr Sumit Konar from the School of Chemistry recently collaborated with University College London and Eli Lilly and Company on a paper that has now been accepted in JACS. The paper details research that comnbined multiple methods to find the crystal structures of all 10 unsolvated polymorphs of galunisertib, which is currently undergoing trials as a cancer drug.

More Information

Thursday, August 15, 2019